search
Back to results

Weaning Preterm Neonates From Nasal Continuous Positive Airway Pressure

Primary Purpose

Respiratory Distress Syndrome, Hyaline Membrane Disease, Preterm Infants

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
CPAP
Nasal Cannula
Sponsored by
Mansoura University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Distress Syndrome focused on measuring Nasal Continuous positive Airway pressure, Nasal Cannula, CPAP, Premature, RDS, HMD, NICU

Eligibility Criteria

28 Weeks - 36 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Infants born greater than or equal to 28 weeks (28+0) and less than 37 weeks (36+6) gestation
  • CPAP pressure of 5 cm H2O
  • FiO2 requirement = or <0.30
  • Clinically stable on these CPAP parameters for 24 hours pre-randomization:

    • Respiratory rate less than 60
    • No significant chest recession
    • No apnea requiring bagging and/or
    • Not more than 6 apneas requiring stimulation in the preceding 24 h.
    • Average saturation > or = 87%
    • Satisfactory ABG (pH> 7.25, PCO2 < 60, and Base deficit < -8)

Exclusion Criteria:

  • Life threatening congenital anomalies
  • Congenital cyanotic heart diseases
  • Congenital airway or chest wall abnormalities
  • Pulmonary hypoplasia
  • Known or suspected to have a neuromuscular disorder
  • Congenital neurological disorder, severe IVH (grade 3 or 4), PVL and hydrocephalus

Sites / Locations

  • Mansoura University Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

CPAP group

Nasal Cannula Group

Arm Description

Subjects in this group will continue receiving CPAP until no oxygen requirement for 24 hours, then will be weaned off CPAP completely as long as they tolerate. CPAP will be re-instituted if subjects meet failing criteria. Another trial off CPAP will start 24 hours after failure and/or after being on 21% for 24 hours. CPAP will be weaned off directly to room air at all times.

Subjects will be weaned from CPAP (when FiO2 <0.30) to Nasal cannula (2 L/min) with whatever FiO2 they need until they are off oxygen and NC completely. However, if these infants fail on NC they will be put back to nCPAP. Infants will then be maintained on CPAP until stable on CPAP-30% for 24 hours. Infants will be tried for another weaning using NC. So, infants assigned to NC will be weaned only through NC. CPAP will be used only for stabilization in between trials if needed.

Outcomes

Primary Outcome Measures

Duration of oxygen use
The number of days for oxygen use from the start of randomization until hospital discharge will be recorded.

Secondary Outcome Measures

Length of respiratory support
The number of days in which the subject requires any sort of respiratory support will be recorded, including: CPAP, nasal cannula and mechanical ventilation.

Full Information

First Posted
March 24, 2010
Last Updated
March 24, 2010
Sponsor
Mansoura University
search

1. Study Identification

Unique Protocol Identification Number
NCT01093495
Brief Title
Weaning Preterm Neonates From Nasal Continuous Positive Airway Pressure
Official Title
A Randomized Controlled Trial on Weaning Preterm Neonates From Nasal Continuous Positive Airway Pressure
Study Type
Interventional

2. Study Status

Record Verification Date
March 2010
Overall Recruitment Status
Completed
Study Start Date
January 2009 (undefined)
Primary Completion Date
December 2009 (Actual)
Study Completion Date
January 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Mansoura University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
There is little data published concerning the best approach to nasal continuous positive airway pressure (nCPAP) weaning. Potential complications associated with prolonged nCPAP therapy include gastric distension, nasal trauma,pneumothorax,agitation and nosocomial infection. Moreover, Infants on nCPAP may also require more intensive nursing care and the use of extra equipment. Therefore, minimizing the amount of time that a patient requires CPAP may be beneficial. On the other hand, removing CPAP too early may lead to complications that include: increasing apnea, increased oxygen requirement, increased work of breathing, the need to re-start CPAP, and intubation and mechanical ventilation. Moreover, an experimental study have demonstrated an improvement in lung growth after the prolonged use of CPAP. Nasal cannula (NC) flows at 1-2 L/min may also generate a positive pressure in the airway of preterm infants. The use of NC flow to generate positive airway pressure would minimize many of the application issues of nCPAP. However, NC systems used in neonates routinely employ gas that is inadequately warmed and humidified, limiting the use of such flows due to increased risk of nasal mucosa injury, and possibly increasing the risk for nosocomial infection. The purpose of this randomized controlled trial is to evaluate the clinical impact of two methods for weaning preterm infants from nCPAP.
Detailed Description
The objective of this study is to test the null hypothesis that in preterm infants with gestational age of 28 to 36 weeks who are stable on CPAP pressure of 5 cmH2O and with oxygen concentrations (FiO2) <0.30, keeping these infants on CPAP or changing them to NC flow of 1-2 L/min will not make any difference in length of hospitalization, length of respiratory support and incidence of complications.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Distress Syndrome, Hyaline Membrane Disease, Preterm Infants, Premature Infants
Keywords
Nasal Continuous positive Airway pressure, Nasal Cannula, CPAP, Premature, RDS, HMD, NICU

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CPAP group
Arm Type
Experimental
Arm Description
Subjects in this group will continue receiving CPAP until no oxygen requirement for 24 hours, then will be weaned off CPAP completely as long as they tolerate. CPAP will be re-instituted if subjects meet failing criteria. Another trial off CPAP will start 24 hours after failure and/or after being on 21% for 24 hours. CPAP will be weaned off directly to room air at all times.
Arm Title
Nasal Cannula Group
Arm Type
Experimental
Arm Description
Subjects will be weaned from CPAP (when FiO2 <0.30) to Nasal cannula (2 L/min) with whatever FiO2 they need until they are off oxygen and NC completely. However, if these infants fail on NC they will be put back to nCPAP. Infants will then be maintained on CPAP until stable on CPAP-30% for 24 hours. Infants will be tried for another weaning using NC. So, infants assigned to NC will be weaned only through NC. CPAP will be used only for stabilization in between trials if needed.
Intervention Type
Device
Intervention Name(s)
CPAP
Intervention Description
CPAP
Intervention Type
Device
Intervention Name(s)
Nasal Cannula
Intervention Description
Nasal Cannula
Primary Outcome Measure Information:
Title
Duration of oxygen use
Description
The number of days for oxygen use from the start of randomization until hospital discharge will be recorded.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Length of respiratory support
Description
The number of days in which the subject requires any sort of respiratory support will be recorded, including: CPAP, nasal cannula and mechanical ventilation.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
28 Weeks
Maximum Age & Unit of Time
36 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Infants born greater than or equal to 28 weeks (28+0) and less than 37 weeks (36+6) gestation CPAP pressure of 5 cm H2O FiO2 requirement = or <0.30 Clinically stable on these CPAP parameters for 24 hours pre-randomization: Respiratory rate less than 60 No significant chest recession No apnea requiring bagging and/or Not more than 6 apneas requiring stimulation in the preceding 24 h. Average saturation > or = 87% Satisfactory ABG (pH> 7.25, PCO2 < 60, and Base deficit < -8) Exclusion Criteria: Life threatening congenital anomalies Congenital cyanotic heart diseases Congenital airway or chest wall abnormalities Pulmonary hypoplasia Known or suspected to have a neuromuscular disorder Congenital neurological disorder, severe IVH (grade 3 or 4), PVL and hydrocephalus
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hesham Abdel Hady, MD
Organizational Affiliation
Mansoura University Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mansoura University Children's Hospital
City
Mansoura
Country
Egypt

12. IPD Sharing Statement

Citations:
PubMed Identifier
12076463
Citation
Ho JJ, Henderson-Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2002;2002(2):CD002975. doi: 10.1002/14651858.CD002975.
Results Reference
background
PubMed Identifier
12076445
Citation
Ho JJ, Subramaniam P, Henderson-Smart DJ, Davis PG. Continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2002;(2):CD002271. doi: 10.1002/14651858.CD002271.
Results Reference
background
PubMed Identifier
15930230
Citation
Aly H, Massaro AN, Patel K, El-Mohandes AA. Is it safer to intubate premature infants in the delivery room? Pediatrics. 2005 Jun;115(6):1660-5. doi: 10.1542/peds.2004-2493.
Results Reference
background
PubMed Identifier
19564301
Citation
Aly H, Massaro AN, Hammad TA, Narang S, Essers J. Early nasal continuous positive airway pressure and necrotizing enterocolitis in preterm infants. Pediatrics. 2009 Jul;124(1):205-10. doi: 10.1542/peds.2008-2588.
Results Reference
background
PubMed Identifier
18977958
Citation
Abdel-Hady H, Matter M, Hammad A, El-Refaay A, Aly H. Hemodynamic changes during weaning from nasal continuous positive airway pressure. Pediatrics. 2008 Nov;122(5):e1086-90. doi: 10.1542/peds.2008-1193. Erratum In: Pediatrics. 2009 Aug;124(2):847.
Results Reference
background
PubMed Identifier
17403854
Citation
Aly H. Is there a strategy for preventing bronchopulmonary dysplasia? Absence of evidence is not evidence of absence. Pediatrics. 2007 Apr;119(4):818-20. doi: 10.1542/peds.2006-3026. No abstract available.
Results Reference
background
PubMed Identifier
16855619
Citation
Aly H, Massaro AN, El-Mohandes AA. Can delivery room management impact the length of hospital stay in premature infants? J Perinatol. 2006 Oct;26(10):593-6. doi: 10.1038/sj.jp.7211575. Epub 2006 Jul 20.
Results Reference
background
PubMed Identifier
15342841
Citation
Aly H, Milner JD, Patel K, El-Mohandes AA. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants? Pediatrics. 2004 Sep;114(3):697-702. doi: 10.1542/peds.2003-0572-L.
Results Reference
background
PubMed Identifier
21276671
Citation
Abdel-Hady H, Shouman B, Aly H. Early weaning from CPAP to high flow nasal cannula in preterm infants is associated with prolonged oxygen requirement: a randomized controlled trial. Early Hum Dev. 2011 Mar;87(3):205-8. doi: 10.1016/j.earlhumdev.2010.12.010. Epub 2011 Jan 26.
Results Reference
derived

Learn more about this trial

Weaning Preterm Neonates From Nasal Continuous Positive Airway Pressure

We'll reach out to this number within 24 hrs